HCW Biologics Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HCW Biologics Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $1.65K, a 26.65% decline year-over-year.
- HCW Biologics Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $2.25K, a 18.62% increase year-over-year.
- HCW Biologics Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $84.00, a 94.98% decline year-over-year.
- HCW Biologics Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $7.71K, a 28.53% increase year-over-year.
- HCW Biologics Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $1.65K, a 32.32% decline from fiscal 2024.
- HCW Biologics Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $2.44K, a 89.70% decline from fiscal 2023.
- HCW Biologics Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $23.74K, a 50.46% increase from fiscal 2022.
- HCW Biologics Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $15.78K, a 46.58% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $1.65K 10-K · filed 2026-03-31 | |
| 2025-03-31 | $1.65K 10-Q/A · filed 2026-08-14 | |
| 2024-12-31 | $2.44K 10-K · filed 2026-03-31 | |
| 2024-03-31 | $2.25K 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $23.74K 10-K/A · filed 2024-05-15 | |
| 2023-09-30 | $84.00 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $7.71K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $1.90K 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $15.78K 10-K/A · filed 2024-05-15 | |
| 2022-09-30 | $1.67K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $6.00K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $2.27K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $29.54K 10-K · filed 2023-03-28 | |
| 2021-09-30 | $576.00 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $9.46K 10-Q · filed 2022-11-07 | |
| 2021-03-31 | $13.38K 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $9.90K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $814.00 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $2.31K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |